Catalyst Wire Dossier Catalyst Wire Dossier

Remimazolam besylate

remimazolam besylate
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Remimazolam besylate, covering 2022-09-15 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients [Phase 2]

See pricing